{"idB": "749647_12_item1a_p43_s0", "idA": "749647_11_item1a_p0_s2", "sentA": "You should understand that it is not possible to predict or identify all such factors.", "sentB": "The commercial potential of a drug candidate in development is difficult to predict.", "type": 1, "words": ["<tag1>", "You", "should", "understand", "that", "it", "is", "not", "possible", "to", "predict", "or", "identify", "all", "such", "factors.", "<tag2>", "The", "commercial", "potential", "of", "a", "drug", "candidate", "in", "development", "is", "difficult", "to", "predict.", "<tag3>"], "wordsA": ["You", "should", "understand", "that", "it", "is", "not", "possible", "to", "predict", "or", "identify", "all", "such", "factors."], "wordsB": ["The", "commercial", "potential", "of", "a", "drug", "candidate", "in", "development", "is", "difficult", "to", "predict."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item1a_p9_s3", "idA": "749647_11_item1a_p15_s1", "sentA": "We have entered into license agreements with Duke University, under which we have exclusive rights to commercialize medical treatment products and procedures based on Duke s thermo-sensitive liposome technology.", "sentB": "We currently only have one collaboration partner , Yakult, under a development, product supply and commercialization agreement, as amended, under which we may receive royalties on the sale of ThermoDox in Japan, when and if any such sales occur.", "type": 1, "words": ["<tag1>", "We", "have", "entered", "into", "license", "agreements", "with", "Duke", "University,", "under", "which", "we", "have", "exclusive", "rights", "to", "commercialize", "medical", "treatment", "products", "and", "procedures", "based", "on", "Duke", "s", "thermo-sensitive", "liposome", "technology.", "<tag2>", "We", "currently", "only", "have", "one", "collaboration", "partner", ",", "Yakult,", "under", "a", "development,", "product", "supply", "and", "commercialization", "agreement,", "as", "amended,", "under", "which", "we", "may", "receive", "royalties", "on", "the", "sale", "of", "ThermoDox", "in", "Japan,", "when", "and", "if", "any", "such", "sales", "occur.", "<tag3>"], "wordsA": ["We", "have", "entered", "into", "license", "agreements", "with", "Duke", "University,", "under", "which", "we", "have", "exclusive", "rights", "to", "commercialize", "medical", "treatment", "products", "and", "procedures", "based", "on", "Duke", "s", "thermo-sensitive", "liposome", "technology."], "wordsB": ["We", "currently", "only", "have", "one", "collaboration", "partner", ",", "Yakult,", "under", "a", "development,", "product", "supply", "and", "commercialization", "agreement,", "as", "amended,", "under", "which", "we", "may", "receive", "royalties", "on", "the", "sale", "of", "ThermoDox", "in", "Japan,", "when", "and", "if", "any", "such", "sales", "occur."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item1a_p53_s1", "idA": "749647_11_item1a_p16_s0", "sentA": "Further, we cannot guarantee that any patent or other technology rights licensed to us by others will not be challenged or circumvented successfully by third parties, or that the rights granted will provide adequate protection.", "sentB": "We believe that the level of interest by others in investigating the potential of possible competitive treatments and alternative technologies will continue and may increase.", "type": 1, "words": ["<tag1>", "Further,", "we", "cannot", "guarantee", "that", "any", "patent", "or", "other", "technology", "rights", "licensed", "to", "us", "by", "others", "will", "not", "be", "challenged", "or", "circumvented", "successfully", "by", "third", "parties,", "or", "that", "the", "rights", "granted", "will", "provide", "adequate", "protection.", "<tag2>", "We", "believe", "that", "the", "level", "of", "interest", "by", "others", "in", "investigating", "the", "potential", "of", "possible", "competitive", "treatments", "and", "alternative", "technologies", "will", "continue", "and", "may", "increase.", "<tag3>"], "wordsA": ["Further,", "we", "cannot", "guarantee", "that", "any", "patent", "or", "other", "technology", "rights", "licensed", "to", "us", "by", "others", "will", "not", "be", "challenged", "or", "circumvented", "successfully", "by", "third", "parties,", "or", "that", "the", "rights", "granted", "will", "provide", "adequate", "protection."], "wordsB": ["We", "believe", "that", "the", "level", "of", "interest", "by", "others", "in", "investigating", "the", "potential", "of", "possible", "competitive", "treatments", "and", "alternative", "technologies", "will", "continue", "and", "may", "increase."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item1a_p61_s1", "idA": "749647_11_item1a_p16_s4", "sentA": "We cannot guarantee that these agreements will not be breached, that, even if not breached, that they are adequate to protect our trade secrets, that we will have adequate remedies for any breach, or that our trade secrets will not otherwise become known to, or will not be discovered independently by, competitors.", "sentB": "On May 10, 2011, we received a letter from NASDAQ stating that our MVLS had been $35 million or greater for the previous ten consecutive business days (from April 26, 2011 to May 9, 2011) and that we had regained compliance with the Rule.", "type": 1, "words": ["<tag1>", "We", "cannot", "guarantee", "that", "these", "agreements", "will", "not", "be", "breached,", "that,", "even", "if", "not", "breached,", "that", "they", "are", "adequate", "to", "protect", "our", "trade", "secrets,", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "our", "trade", "secrets", "will", "not", "otherwise", "become", "known", "to,", "or", "will", "not", "be", "discovered", "independently", "by,", "competitors.", "<tag2>", "On", "May", "10,", "2011,", "we", "received", "a", "letter", "from", "NASDAQ", "stating", "that", "our", "MVLS", "had", "been", "$35", "million", "or", "greater", "for", "the", "previous", "ten", "consecutive", "business", "days", "(from", "April", "26,", "2011", "to", "May", "9,", "2011)", "and", "that", "we", "had", "regained", "compliance", "with", "the", "Rule.", "<tag3>"], "wordsA": ["We", "cannot", "guarantee", "that", "these", "agreements", "will", "not", "be", "breached,", "that,", "even", "if", "not", "breached,", "that", "they", "are", "adequate", "to", "protect", "our", "trade", "secrets,", "that", "we", "will", "have", "adequate", "remedies", "for", "any", "breach,", "or", "that", "our", "trade", "secrets", "will", "not", "otherwise", "become", "known", "to,", "or", "will", "not", "be", "discovered", "independently", "by,", "competitors."], "wordsB": ["On", "May", "10,", "2011,", "we", "received", "a", "letter", "from", "NASDAQ", "stating", "that", "our", "MVLS", "had", "been", "$35", "million", "or", "greater", "for", "the", "previous", "ten", "consecutive", "business", "days", "(from", "April", "26,", "2011", "to", "May", "9,", "2011)", "and", "that", "we", "had", "regained", "compliance", "with", "the", "Rule."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item1a_p44_s0", "idA": "749647_11_item1a_p24_s1", "sentA": "If the results of pivotal clinical trials do not establish the safety and efficacy of our product candidates to the satisfaction of the FDA and other foreign regulatory agencies, we will not receive the approvals necessary to market such product candidates.", "sentB": "It is very difficult to estimate the commercial potential of product candidates due to important factors such as safety and efficacy compared to other available treatments, including potential generic drug alternatives with similar efficacy profiles, changing standards of care, third party payer reimbursement standards, patient and physician preferences, the availability of competitive alternatives that may emerge either during the long drug development process or after commercial introduction, and the availability of generic versions of our successful product candidates following approval by government health authorities based on the expiration of regulatory exclusivity or our inability to prevent generic versions from coming to market by asserting our patents.", "type": 1, "words": ["<tag1>", "If", "the", "results", "of", "pivotal", "clinical", "trials", "do", "not", "establish", "the", "safety", "and", "efficacy", "of", "our", "product", "candidates", "to", "the", "satisfaction", "of", "the", "FDA", "and", "other", "foreign", "regulatory", "agencies,", "we", "will", "not", "receive", "the", "approvals", "necessary", "to", "market", "such", "product", "candidates.", "<tag2>", "It", "is", "very", "difficult", "to", "estimate", "the", "commercial", "potential", "of", "product", "candidates", "due", "to", "important", "factors", "such", "as", "safety", "and", "efficacy", "compared", "to", "other", "available", "treatments,", "including", "potential", "generic", "drug", "alternatives", "with", "similar", "efficacy", "profiles,", "changing", "standards", "of", "care,", "third", "party", "payer", "reimbursement", "standards,", "patient", "and", "physician", "preferences,", "the", "availability", "of", "competitive", "alternatives", "that", "may", "emerge", "either", "during", "the", "long", "drug", "development", "process", "or", "after", "commercial", "introduction,", "and", "the", "availability", "of", "generic", "versions", "of", "our", "successful", "product", "candidates", "following", "approval", "by", "government", "health", "authorities", "based", "on", "the", "expiration", "of", "regulatory", "exclusivity", "or", "our", "inability", "to", "prevent", "generic", "versions", "from", "coming", "to", "market", "by", "asserting", "our", "patents.", "<tag3>"], "wordsA": ["If", "the", "results", "of", "pivotal", "clinical", "trials", "do", "not", "establish", "the", "safety", "and", "efficacy", "of", "our", "product", "candidates", "to", "the", "satisfaction", "of", "the", "FDA", "and", "other", "foreign", "regulatory", "agencies,", "we", "will", "not", "receive", "the", "approvals", "necessary", "to", "market", "such", "product", "candidates."], "wordsB": ["It", "is", "very", "difficult", "to", "estimate", "the", "commercial", "potential", "of", "product", "candidates", "due", "to", "important", "factors", "such", "as", "safety", "and", "efficacy", "compared", "to", "other", "available", "treatments,", "including", "potential", "generic", "drug", "alternatives", "with", "similar", "efficacy", "profiles,", "changing", "standards", "of", "care,", "third", "party", "payer", "reimbursement", "standards,", "patient", "and", "physician", "preferences,", "the", "availability", "of", "competitive", "alternatives", "that", "may", "emerge", "either", "during", "the", "long", "drug", "development", "process", "or", "after", "commercial", "introduction,", "and", "the", "availability", "of", "generic", "versions", "of", "our", "successful", "product", "candidates", "following", "approval", "by", "government", "health", "authorities", "based", "on", "the", "expiration", "of", "regulatory", "exclusivity", "or", "our", "inability", "to", "prevent", "generic", "versions", "from", "coming", "to", "market", "by", "asserting", "our", "patents."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item1a_p4_s3", "idA": "749647_11_item1a_p28_s1", "sentA": "These regulations require, among other things, the reporting to the FDA of adverse events alleged to have been associated with the use of a product or in connection with certain product failures.", "sentB": "The start or end of a clinical study is often delayed or halted due to changing regulatory requirements, manufacturing challenges, required clinical trial administrative actions, slower than anticipated patient enrollment, changing standards of care, availability or prevalence of use of a comparator drug or required prior therapy, clinical outcomes or our own financial constraints.", "type": 1, "words": ["<tag1>", "These", "regulations", "require,", "among", "other", "things,", "the", "reporting", "to", "the", "FDA", "of", "adverse", "events", "alleged", "to", "have", "been", "associated", "with", "the", "use", "of", "a", "product", "or", "in", "connection", "with", "certain", "product", "failures.", "<tag2>", "The", "start", "or", "end", "of", "a", "clinical", "study", "is", "often", "delayed", "or", "halted", "due", "to", "changing", "regulatory", "requirements,", "manufacturing", "challenges,", "required", "clinical", "trial", "administrative", "actions,", "slower", "than", "anticipated", "patient", "enrollment,", "changing", "standards", "of", "care,", "availability", "or", "prevalence", "of", "use", "of", "a", "comparator", "drug", "or", "required", "prior", "therapy,", "clinical", "outcomes", "or", "our", "own", "financial", "constraints.", "<tag3>"], "wordsA": ["These", "regulations", "require,", "among", "other", "things,", "the", "reporting", "to", "the", "FDA", "of", "adverse", "events", "alleged", "to", "have", "been", "associated", "with", "the", "use", "of", "a", "product", "or", "in", "connection", "with", "certain", "product", "failures."], "wordsB": ["The", "start", "or", "end", "of", "a", "clinical", "study", "is", "often", "delayed", "or", "halted", "due", "to", "changing", "regulatory", "requirements,", "manufacturing", "challenges,", "required", "clinical", "trial", "administrative", "actions,", "slower", "than", "anticipated", "patient", "enrollment,", "changing", "standards", "of", "care,", "availability", "or", "prevalence", "of", "use", "of", "a", "comparator", "drug", "or", "required", "prior", "therapy,", "clinical", "outcomes", "or", "our", "own", "financial", "constraints."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item1a_p4_s2", "idA": "749647_11_item1a_p33_s1", "sentA": "There have been a number of government and private sector initiatives during the last few years to limit the growth of healthcare costs, including price regulation, competitive pricing, coverage and payment policies, comparative effectiveness of therapies, technology assessments and managed-care arrangements.", "sentB": "It will take us several years to complete clinical studies.", "type": 1, "words": ["<tag1>", "There", "have", "been", "a", "number", "of", "government", "and", "private", "sector", "initiatives", "during", "the", "last", "few", "years", "to", "limit", "the", "growth", "of", "healthcare", "costs,", "including", "price", "regulation,", "competitive", "pricing,", "coverage", "and", "payment", "policies,", "comparative", "effectiveness", "of", "therapies,", "technology", "assessments", "and", "managed-care", "arrangements.", "<tag2>", "It", "will", "take", "us", "several", "years", "to", "complete", "clinical", "studies.", "<tag3>"], "wordsA": ["There", "have", "been", "a", "number", "of", "government", "and", "private", "sector", "initiatives", "during", "the", "last", "few", "years", "to", "limit", "the", "growth", "of", "healthcare", "costs,", "including", "price", "regulation,", "competitive", "pricing,", "coverage", "and", "payment", "policies,", "comparative", "effectiveness", "of", "therapies,", "technology", "assessments", "and", "managed-care", "arrangements."], "wordsB": ["It", "will", "take", "us", "several", "years", "to", "complete", "clinical", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item1a_p3_s0", "idA": "749647_11_item1a_p41_s0", "sentA": "Various methods for treating cancer currently are, and in the future are expected to be, the subject of extensive research and development.", "sentB": "Drug development is an inherent uncertain process with a high risk of failure at every stage of development.", "type": 1, "words": ["<tag1>", "Various", "methods", "for", "treating", "cancer", "currently", "are,", "and", "in", "the", "future", "are", "expected", "to", "be,", "the", "subject", "of", "extensive", "research", "and", "development.", "<tag2>", "Drug", "development", "is", "an", "inherent", "uncertain", "process", "with", "a", "high", "risk", "of", "failure", "at", "every", "stage", "of", "development.", "<tag3>"], "wordsA": ["Various", "methods", "for", "treating", "cancer", "currently", "are,", "and", "in", "the", "future", "are", "expected", "to", "be,", "the", "subject", "of", "extensive", "research", "and", "development."], "wordsB": ["Drug", "development", "is", "an", "inherent", "uncertain", "process", "with", "a", "high", "risk", "of", "failure", "at", "every", "stage", "of", "development."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item1a_p0_s4", "idA": "749647_11_item1a_p46_s3", "sentA": "We will be unable to manage our business effectively if we are unable to alleviate the strain on resources caused by growth in a timely and successful manner.", "sentB": "Moreover, we operate in a competitive and rapidly changing environment.", "type": 1, "words": ["<tag1>", "We", "will", "be", "unable", "to", "manage", "our", "business", "effectively", "if", "we", "are", "unable", "to", "alleviate", "the", "strain", "on", "resources", "caused", "by", "growth", "in", "a", "timely", "and", "successful", "manner.", "<tag2>", "Moreover,", "we", "operate", "in", "a", "competitive", "and", "rapidly", "changing", "environment.", "<tag3>"], "wordsA": ["We", "will", "be", "unable", "to", "manage", "our", "business", "effectively", "if", "we", "are", "unable", "to", "alleviate", "the", "strain", "on", "resources", "caused", "by", "growth", "in", "a", "timely", "and", "successful", "manner."], "wordsB": ["Moreover,", "we", "operate", "in", "a", "competitive", "and", "rapidly", "changing", "environment."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item1a_p62_s2", "idA": "749647_11_item1a_p54_s0", "sentA": "the trading volume of our common stock.", "sentB": "An investor is likely to find it less convenient to sell, or to obtain accurate quotations in seeking to buy, our common stock on an over-the-counter market, and many investors may not buy or sell our common stock due to difficulty in accessing over-the-counter markets, or due to policies preventing them from trading in securities not listed on a national exchange or other reasons.", "type": 1, "words": ["<tag1>", "the", "trading", "volume", "of", "our", "common", "stock.", "<tag2>", "An", "investor", "is", "likely", "to", "find", "it", "less", "convenient", "to", "sell,", "or", "to", "obtain", "accurate", "quotations", "in", "seeking", "to", "buy,", "our", "common", "stock", "on", "an", "over-the-counter", "market,", "and", "many", "investors", "may", "not", "buy", "or", "sell", "our", "common", "stock", "due", "to", "difficulty", "in", "accessing", "over-the-counter", "markets,", "or", "due", "to", "policies", "preventing", "them", "from", "trading", "in", "securities", "not", "listed", "on", "a", "national", "exchange", "or", "other", "reasons.", "<tag3>"], "wordsA": ["the", "trading", "volume", "of", "our", "common", "stock."], "wordsB": ["An", "investor", "is", "likely", "to", "find", "it", "less", "convenient", "to", "sell,", "or", "to", "obtain", "accurate", "quotations", "in", "seeking", "to", "buy,", "our", "common", "stock", "on", "an", "over-the-counter", "market,", "and", "many", "investors", "may", "not", "buy", "or", "sell", "our", "common", "stock", "due", "to", "difficulty", "in", "accessing", "over-the-counter", "markets,", "or", "due", "to", "policies", "preventing", "them", "from", "trading", "in", "securities", "not", "listed", "on", "a", "national", "exchange", "or", "other", "reasons."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item1a_p57_s1", "idA": "749647_11_item1a_p55_s2", "sentA": "These broad market and industry factors may materially harm the market price of our common stock and expose us to securities class action litigation.", "sentB": "The price at which our common stock trades depends upon a number of factors, including our historical and anticipated operating results, our financial situation, announcements of technological innovations or new products by us or our competitors, our ability or inability to raise the additional capital we may need and the terms on which we raise it, and general market and economic conditions.", "type": 1, "words": ["<tag1>", "These", "broad", "market", "and", "industry", "factors", "may", "materially", "harm", "the", "market", "price", "of", "our", "common", "stock", "and", "expose", "us", "to", "securities", "class", "action", "litigation.", "<tag2>", "The", "price", "at", "which", "our", "common", "stock", "trades", "depends", "upon", "a", "number", "of", "factors,", "including", "our", "historical", "and", "anticipated", "operating", "results,", "our", "financial", "situation,", "announcements", "of", "technological", "innovations", "or", "new", "products", "by", "us", "or", "our", "competitors,", "our", "ability", "or", "inability", "to", "raise", "the", "additional", "capital", "we", "may", "need", "and", "the", "terms", "on", "which", "we", "raise", "it,", "and", "general", "market", "and", "economic", "conditions.", "<tag3>"], "wordsA": ["These", "broad", "market", "and", "industry", "factors", "may", "materially", "harm", "the", "market", "price", "of", "our", "common", "stock", "and", "expose", "us", "to", "securities", "class", "action", "litigation."], "wordsB": ["The", "price", "at", "which", "our", "common", "stock", "trades", "depends", "upon", "a", "number", "of", "factors,", "including", "our", "historical", "and", "anticipated", "operating", "results,", "our", "financial", "situation,", "announcements", "of", "technological", "innovations", "or", "new", "products", "by", "us", "or", "our", "competitors,", "our", "ability", "or", "inability", "to", "raise", "the", "additional", "capital", "we", "may", "need", "and", "the", "terms", "on", "which", "we", "raise", "it,", "and", "general", "market", "and", "economic", "conditions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item1a_p61_s0", "idA": "749647_11_item1a_p59_s0", "sentA": "While our Common Stock is listed on the NASDAQ Capital Market, the volume of trading historically has been relatively light.", "sentB": "On April 6, 2011, we received notice from The NASDAQ Listing Qualifications Department that we were not in compliance with the minimum Market Value of Listed Securities (MVLS) requirement for continued listing on The NASDAQ Capital Market, as set forth in NASDAQ Listing Rule 5550(b)(2) (the Rule), which requires a listed company to maintain a minimum MVLS of $35 million.", "type": 1, "words": ["<tag1>", "While", "our", "Common", "Stock", "is", "listed", "on", "the", "NASDAQ", "Capital", "Market,", "the", "volume", "of", "trading", "historically", "has", "been", "relatively", "light.", "<tag2>", "On", "April", "6,", "2011,", "we", "received", "notice", "from", "The", "NASDAQ", "Listing", "Qualifications", "Department", "that", "we", "were", "not", "in", "compliance", "with", "the", "minimum", "Market", "Value", "of", "Listed", "Securities", "(MVLS)", "requirement", "for", "continued", "listing", "on", "The", "NASDAQ", "Capital", "Market,", "as", "set", "forth", "in", "NASDAQ", "Listing", "Rule", "5550(b)(2)", "(the", "Rule),", "which", "requires", "a", "listed", "company", "to", "maintain", "a", "minimum", "MVLS", "of", "$35", "million.", "<tag3>"], "wordsA": ["While", "our", "Common", "Stock", "is", "listed", "on", "the", "NASDAQ", "Capital", "Market,", "the", "volume", "of", "trading", "historically", "has", "been", "relatively", "light."], "wordsB": ["On", "April", "6,", "2011,", "we", "received", "notice", "from", "The", "NASDAQ", "Listing", "Qualifications", "Department", "that", "we", "were", "not", "in", "compliance", "with", "the", "minimum", "Market", "Value", "of", "Listed", "Securities", "(MVLS)", "requirement", "for", "continued", "listing", "on", "The", "NASDAQ", "Capital", "Market,", "as", "set", "forth", "in", "NASDAQ", "Listing", "Rule", "5550(b)(2)", "(the", "Rule),", "which", "requires", "a", "listed", "company", "to", "maintain", "a", "minimum", "MVLS", "of", "$35", "million."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_12_item1a_p13_s0", "idA": "749647_11_item1a_p60_s0", "sentA": "We have never paid cash dividends on our Common Stock and do not anticipate paying cash dividends on our common stock in the foreseeable future.", "sentB": "We have no internal sales or marketing capability.", "type": 1, "words": ["<tag1>", "We", "have", "never", "paid", "cash", "dividends", "on", "our", "Common", "Stock", "and", "do", "not", "anticipate", "paying", "cash", "dividends", "on", "our", "common", "stock", "in", "the", "foreseeable", "future.", "<tag2>", "We", "have", "no", "internal", "sales", "or", "marketing", "capability.", "<tag3>"], "wordsA": ["We", "have", "never", "paid", "cash", "dividends", "on", "our", "Common", "Stock", "and", "do", "not", "anticipate", "paying", "cash", "dividends", "on", "our", "common", "stock", "in", "the", "foreseeable", "future."], "wordsB": ["We", "have", "no", "internal", "sales", "or", "marketing", "capability."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p65_s0", "idA": "749647_12_item1a_p14_s1", "sentA": "We intend to market our products, if and when such products are approved for commercialization by the FDA, either directly or through other strategic alliances and distribution arrangements with third parties.", "sentB": "We may seek to raise necessary funds through public or private equity offerings, debt financings or additional strategic alliances and licensing arrangements.", "type": 1, "words": ["<tag1>", "We", "intend", "to", "market", "our", "products,", "if", "and", "when", "such", "products", "are", "approved", "for", "commercialization", "by", "the", "FDA,", "either", "directly", "or", "through", "other", "strategic", "alliances", "and", "distribution", "arrangements", "with", "third", "parties.", "<tag2>", "We", "may", "seek", "to", "raise", "necessary", "funds", "through", "public", "or", "private", "equity", "offerings,", "debt", "financings", "or", "additional", "strategic", "alliances", "and", "licensing", "arrangements.", "<tag3>"], "wordsA": ["We", "intend", "to", "market", "our", "products,", "if", "and", "when", "such", "products", "are", "approved", "for", "commercialization", "by", "the", "FDA,", "either", "directly", "or", "through", "other", "strategic", "alliances", "and", "distribution", "arrangements", "with", "third", "parties."], "wordsB": ["We", "may", "seek", "to", "raise", "necessary", "funds", "through", "public", "or", "private", "equity", "offerings,", "debt", "financings", "or", "additional", "strategic", "alliances", "and", "licensing", "arrangements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p83_s2", "idA": "749647_12_item1a_p16_s3", "sentA": "If we breach these or other provisions of the license and research agreements, we will lose our ability to use the subject technology, as well as compensation for our efforts in developing or exploiting the technology.", "sentB": "During 2012 and 2011, the Company performed analyses to determine if there were changes in ownership, as defined by Section 382 of the Internal Revenue Code that would limit its ability to utilize certain net operating loss and tax credit carryforwards.", "type": 1, "words": ["<tag1>", "If", "we", "breach", "these", "or", "other", "provisions", "of", "the", "license", "and", "research", "agreements,", "we", "will", "lose", "our", "ability", "to", "use", "the", "subject", "technology,", "as", "well", "as", "compensation", "for", "our", "efforts", "in", "developing", "or", "exploiting", "the", "technology.", "<tag2>", "During", "2012", "and", "2011,", "the", "Company", "performed", "analyses", "to", "determine", "if", "there", "were", "changes", "in", "ownership,", "as", "defined", "by", "Section", "382", "of", "the", "Internal", "Revenue", "Code", "that", "would", "limit", "its", "ability", "to", "utilize", "certain", "net", "operating", "loss", "and", "tax", "credit", "carryforwards.", "<tag3>"], "wordsA": ["If", "we", "breach", "these", "or", "other", "provisions", "of", "the", "license", "and", "research", "agreements,", "we", "will", "lose", "our", "ability", "to", "use", "the", "subject", "technology,", "as", "well", "as", "compensation", "for", "our", "efforts", "in", "developing", "or", "exploiting", "the", "technology."], "wordsB": ["During", "2012", "and", "2011,", "the", "Company", "performed", "analyses", "to", "determine", "if", "there", "were", "changes", "in", "ownership,", "as", "defined", "by", "Section", "382", "of", "the", "Internal", "Revenue", "Code", "that", "would", "limit", "its", "ability", "to", "utilize", "certain", "net", "operating", "loss", "and", "tax", "credit", "carryforwards."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p57_s0", "idA": "749647_12_item1a_p17_s1", "sentA": "We may be required to alter any of our potential products or processes, or enter into a license and pay licensing fees to a third party or cease certain activities.", "sentB": "merge with, or otherwise enter into a business combination with, another company in which our stockholders would receive cash or shares of the other company or a combination of both on terms that certain of our stockholders may not deem desirable.", "type": 1, "words": ["<tag1>", "We", "may", "be", "required", "to", "alter", "any", "of", "our", "potential", "products", "or", "processes,", "or", "enter", "into", "a", "license", "and", "pay", "licensing", "fees", "to", "a", "third", "party", "or", "cease", "certain", "activities.", "<tag2>", "merge", "with,", "or", "otherwise", "enter", "into", "a", "business", "combination", "with,", "another", "company", "in", "which", "our", "stockholders", "would", "receive", "cash", "or", "shares", "of", "the", "other", "company", "or", "a", "combination", "of", "both", "on", "terms", "that", "certain", "of", "our", "stockholders", "may", "not", "deem", "desirable.", "<tag3>"], "wordsA": ["We", "may", "be", "required", "to", "alter", "any", "of", "our", "potential", "products", "or", "processes,", "or", "enter", "into", "a", "license", "and", "pay", "licensing", "fees", "to", "a", "third", "party", "or", "cease", "certain", "activities."], "wordsB": ["merge", "with,", "or", "otherwise", "enter", "into", "a", "business", "combination", "with,", "another", "company", "in", "which", "our", "stockholders", "would", "receive", "cash", "or", "shares", "of", "the", "other", "company", "or", "a", "combination", "of", "both", "on", "terms", "that", "certain", "of", "our", "stockholders", "may", "not", "deem", "desirable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p67_s2", "idA": "749647_12_item1a_p22_s2", "sentA": "Although we currently are not involved in any material litigation involving patents, a third party patent holder may assert a claim of patent infringement against us in the future.", "sentB": "Plaintiffs securities litigation firms have publicly announced that they are investigating potential securities fraud claims that they may wish to make against us.", "type": 1, "words": ["<tag1>", "Although", "we", "currently", "are", "not", "involved", "in", "any", "material", "litigation", "involving", "patents,", "a", "third", "party", "patent", "holder", "may", "assert", "a", "claim", "of", "patent", "infringement", "against", "us", "in", "the", "future.", "<tag2>", "Plaintiffs", "securities", "litigation", "firms", "have", "publicly", "announced", "that", "they", "are", "investigating", "potential", "securities", "fraud", "claims", "that", "they", "may", "wish", "to", "make", "against", "us.", "<tag3>"], "wordsA": ["Although", "we", "currently", "are", "not", "involved", "in", "any", "material", "litigation", "involving", "patents,", "a", "third", "party", "patent", "holder", "may", "assert", "a", "claim", "of", "patent", "infringement", "against", "us", "in", "the", "future."], "wordsB": ["Plaintiffs", "securities", "litigation", "firms", "have", "publicly", "announced", "that", "they", "are", "investigating", "potential", "securities", "fraud", "claims", "that", "they", "may", "wish", "to", "make", "against", "us."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p5_s4", "idA": "749647_12_item1a_p23_s0", "sentA": "We rely on third parties to conduct all of our clinical trials.", "sentB": "Even if ThermoDox has positive results in its Phase II clinical trials, there is a substantial risk that it will fail to have sufficiently positive results in Phase III clinical trials with regard to efficacy, safety or other clinical outcomes.", "type": 1, "words": ["<tag1>", "We", "rely", "on", "third", "parties", "to", "conduct", "all", "of", "our", "clinical", "trials.", "<tag2>", "Even", "if", "ThermoDox", "has", "positive", "results", "in", "its", "Phase", "II", "clinical", "trials,", "there", "is", "a", "substantial", "risk", "that", "it", "will", "fail", "to", "have", "sufficiently", "positive", "results", "in", "Phase", "III", "clinical", "trials", "with", "regard", "to", "efficacy,", "safety", "or", "other", "clinical", "outcomes.", "<tag3>"], "wordsA": ["We", "rely", "on", "third", "parties", "to", "conduct", "all", "of", "our", "clinical", "trials."], "wordsB": ["Even", "if", "ThermoDox", "has", "positive", "results", "in", "its", "Phase", "II", "clinical", "trials,", "there", "is", "a", "substantial", "risk", "that", "it", "will", "fail", "to", "have", "sufficiently", "positive", "results", "in", "Phase", "III", "clinical", "trials", "with", "regard", "to", "efficacy,", "safety", "or", "other", "clinical", "outcomes."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p84_s1", "idA": "749647_12_item1a_p27_s1", "sentA": "If the results of pivotal clinical trials do not establish the safety and efficacy of our product candidates to the satisfaction of the FDA and other foreign regulatory agencies, we will not receive the approvals necessary to market such product candidates.", "sentB": "As a result, the utilization of the Company s federal tax net operating loss carryforwards generated prior to the ownership change is limited.", "type": 1, "words": ["<tag1>", "If", "the", "results", "of", "pivotal", "clinical", "trials", "do", "not", "establish", "the", "safety", "and", "efficacy", "of", "our", "product", "candidates", "to", "the", "satisfaction", "of", "the", "FDA", "and", "other", "foreign", "regulatory", "agencies,", "we", "will", "not", "receive", "the", "approvals", "necessary", "to", "market", "such", "product", "candidates.", "<tag2>", "As", "a", "result,", "the", "utilization", "of", "the", "Company", "s", "federal", "tax", "net", "operating", "loss", "carryforwards", "generated", "prior", "to", "the", "ownership", "change", "is", "limited.", "<tag3>"], "wordsA": ["If", "the", "results", "of", "pivotal", "clinical", "trials", "do", "not", "establish", "the", "safety", "and", "efficacy", "of", "our", "product", "candidates", "to", "the", "satisfaction", "of", "the", "FDA", "and", "other", "foreign", "regulatory", "agencies,", "we", "will", "not", "receive", "the", "approvals", "necessary", "to", "market", "such", "product", "candidates."], "wordsB": ["As", "a", "result,", "the", "utilization", "of", "the", "Company", "s", "federal", "tax", "net", "operating", "loss", "carryforwards", "generated", "prior", "to", "the", "ownership", "change", "is", "limited."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p10_s2", "idA": "749647_12_item1a_p2_s2", "sentA": "Because we presently have no product revenues and we are committed to continuing our product research, development and commercialization programs, we will continue to experience significant operating losses unless and until we complete the development of ThermoDox and other new products and these products have been clinically tested, approved by the FDA and successfully marketed.", "sentB": "Following our announcement on January 31, 2013 that the HEAT study failed to meet its primary endpoint of progression free survival, we will continue to follow the patients enrolled in the Heat study to the secondary endpoint, overall survival.", "type": 1, "words": ["<tag1>", "Because", "we", "presently", "have", "no", "product", "revenues", "and", "we", "are", "committed", "to", "continuing", "our", "product", "research,", "development", "and", "commercialization", "programs,", "we", "will", "continue", "to", "experience", "significant", "operating", "losses", "unless", "and", "until", "we", "complete", "the", "development", "of", "ThermoDox", "and", "other", "new", "products", "and", "these", "products", "have", "been", "clinically", "tested,", "approved", "by", "the", "FDA", "and", "successfully", "marketed.", "<tag2>", "Following", "our", "announcement", "on", "January", "31,", "2013", "that", "the", "HEAT", "study", "failed", "to", "meet", "its", "primary", "endpoint", "of", "progression", "free", "survival,", "we", "will", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "Heat", "study", "to", "the", "secondary", "endpoint,", "overall", "survival.", "<tag3>"], "wordsA": ["Because", "we", "presently", "have", "no", "product", "revenues", "and", "we", "are", "committed", "to", "continuing", "our", "product", "research,", "development", "and", "commercialization", "programs,", "we", "will", "continue", "to", "experience", "significant", "operating", "losses", "unless", "and", "until", "we", "complete", "the", "development", "of", "ThermoDox", "and", "other", "new", "products", "and", "these", "products", "have", "been", "clinically", "tested,", "approved", "by", "the", "FDA", "and", "successfully", "marketed."], "wordsB": ["Following", "our", "announcement", "on", "January", "31,", "2013", "that", "the", "HEAT", "study", "failed", "to", "meet", "its", "primary", "endpoint", "of", "progression", "free", "survival,", "we", "will", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "Heat", "study", "to", "the", "secondary", "endpoint,", "overall", "survival."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p13_s3", "idA": "749647_12_item1a_p2_s2", "sentA": "Because we presently have no product revenues and we are committed to continuing our product research, development and commercialization programs, we will continue to experience significant operating losses unless and until we complete the development of ThermoDox and other new products and these products have been clinically tested, approved by the FDA and successfully marketed.", "sentB": "We will conduct additional analyses of the data from the HEAT study to assess the future strategic value of ThermoDox and are performing sub-group analysis of the Chinese cohort of patients in the HEAT study and other activities for further development of ThermoDox for mainland China, Hong Kong and Macau.", "type": 1, "words": ["<tag1>", "Because", "we", "presently", "have", "no", "product", "revenues", "and", "we", "are", "committed", "to", "continuing", "our", "product", "research,", "development", "and", "commercialization", "programs,", "we", "will", "continue", "to", "experience", "significant", "operating", "losses", "unless", "and", "until", "we", "complete", "the", "development", "of", "ThermoDox", "and", "other", "new", "products", "and", "these", "products", "have", "been", "clinically", "tested,", "approved", "by", "the", "FDA", "and", "successfully", "marketed.", "<tag2>", "We", "will", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", "and", "are", "performing", "sub-group", "analysis", "of", "the", "Chinese", "cohort", "of", "patients", "in", "the", "HEAT", "study", "and", "other", "activities", "for", "further", "development", "of", "ThermoDox", "for", "mainland", "China,", "Hong", "Kong", "and", "Macau.", "<tag3>"], "wordsA": ["Because", "we", "presently", "have", "no", "product", "revenues", "and", "we", "are", "committed", "to", "continuing", "our", "product", "research,", "development", "and", "commercialization", "programs,", "we", "will", "continue", "to", "experience", "significant", "operating", "losses", "unless", "and", "until", "we", "complete", "the", "development", "of", "ThermoDox", "and", "other", "new", "products", "and", "these", "products", "have", "been", "clinically", "tested,", "approved", "by", "the", "FDA", "and", "successfully", "marketed."], "wordsB": ["We", "will", "conduct", "additional", "analyses", "of", "the", "data", "from", "the", "HEAT", "study", "to", "assess", "the", "future", "strategic", "value", "of", "ThermoDox", "and", "are", "performing", "sub-group", "analysis", "of", "the", "Chinese", "cohort", "of", "patients", "in", "the", "HEAT", "study", "and", "other", "activities", "for", "further", "development", "of", "ThermoDox", "for", "mainland", "China,", "Hong", "Kong", "and", "Macau."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p58_s0", "idA": "749647_12_item1a_p30_s0", "sentA": "Although we have internal compliance programs, if these programs do not meet regulatory agency standards or if our compliance is deemed deficient in any significant way, it could have a material adverse effect on the Company.", "sentB": "Although we intend to evaluate and consider different strategic alternatives, we have no agreements or understandings with respect to any acquisition, reorganization or business combination at this time.", "type": 1, "words": ["<tag1>", "Although", "we", "have", "internal", "compliance", "programs,", "if", "these", "programs", "do", "not", "meet", "regulatory", "agency", "standards", "or", "if", "our", "compliance", "is", "deemed", "deficient", "in", "any", "significant", "way,", "it", "could", "have", "a", "material", "adverse", "effect", "on", "the", "Company.", "<tag2>", "Although", "we", "intend", "to", "evaluate", "and", "consider", "different", "strategic", "alternatives,", "we", "have", "no", "agreements", "or", "understandings", "with", "respect", "to", "any", "acquisition,", "reorganization", "or", "business", "combination", "at", "this", "time.", "<tag3>"], "wordsA": ["Although", "we", "have", "internal", "compliance", "programs,", "if", "these", "programs", "do", "not", "meet", "regulatory", "agency", "standards", "or", "if", "our", "compliance", "is", "deemed", "deficient", "in", "any", "significant", "way,", "it", "could", "have", "a", "material", "adverse", "effect", "on", "the", "Company."], "wordsB": ["Although", "we", "intend", "to", "evaluate", "and", "consider", "different", "strategic", "alternatives,", "we", "have", "no", "agreements", "or", "understandings", "with", "respect", "to", "any", "acquisition,", "reorganization", "or", "business", "combination", "at", "this", "time."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p75_s2", "idA": "749647_12_item1a_p31_s1", "sentA": "These regulations require, among other things, the reporting to the FDA of adverse events alleged to have been associated with the use of a product or in connection with certain product failures.", "sentB": "In connection with the Series A 0% convertible preferred stock offering, the Company agreed to not sell any ATM Shares for a period of one year from February 26, 2013.", "type": 1, "words": ["<tag1>", "These", "regulations", "require,", "among", "other", "things,", "the", "reporting", "to", "the", "FDA", "of", "adverse", "events", "alleged", "to", "have", "been", "associated", "with", "the", "use", "of", "a", "product", "or", "in", "connection", "with", "certain", "product", "failures.", "<tag2>", "In", "connection", "with", "the", "Series", "A", "0%", "convertible", "preferred", "stock", "offering,", "the", "Company", "agreed", "to", "not", "sell", "any", "ATM", "Shares", "for", "a", "period", "of", "one", "year", "from", "February", "26,", "2013.", "<tag3>"], "wordsA": ["These", "regulations", "require,", "among", "other", "things,", "the", "reporting", "to", "the", "FDA", "of", "adverse", "events", "alleged", "to", "have", "been", "associated", "with", "the", "use", "of", "a", "product", "or", "in", "connection", "with", "certain", "product", "failures."], "wordsB": ["In", "connection", "with", "the", "Series", "A", "0%", "convertible", "preferred", "stock", "offering,", "the", "Company", "agreed", "to", "not", "sell", "any", "ATM", "Shares", "for", "a", "period", "of", "one", "year", "from", "February", "26,", "2013."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p84_s0", "idA": "749647_12_item1a_p31_s1", "sentA": "These regulations require, among other things, the reporting to the FDA of adverse events alleged to have been associated with the use of a product or in connection with certain product failures.", "sentB": "The Company determined that it experienced an ownership change, as defined by Section 382, in connection with its registered direct and private placement offerings on July 25, 2011.", "type": 1, "words": ["<tag1>", "These", "regulations", "require,", "among", "other", "things,", "the", "reporting", "to", "the", "FDA", "of", "adverse", "events", "alleged", "to", "have", "been", "associated", "with", "the", "use", "of", "a", "product", "or", "in", "connection", "with", "certain", "product", "failures.", "<tag2>", "The", "Company", "determined", "that", "it", "experienced", "an", "ownership", "change,", "as", "defined", "by", "Section", "382,", "in", "connection", "with", "its", "registered", "direct", "and", "private", "placement", "offerings", "on", "July", "25,", "2011.", "<tag3>"], "wordsA": ["These", "regulations", "require,", "among", "other", "things,", "the", "reporting", "to", "the", "FDA", "of", "adverse", "events", "alleged", "to", "have", "been", "associated", "with", "the", "use", "of", "a", "product", "or", "in", "connection", "with", "certain", "product", "failures."], "wordsB": ["The", "Company", "determined", "that", "it", "experienced", "an", "ownership", "change,", "as", "defined", "by", "Section", "382,", "in", "connection", "with", "its", "registered", "direct", "and", "private", "placement", "offerings", "on", "July", "25,", "2011."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p83_s1", "idA": "749647_12_item1a_p39_s0", "sentA": "The reimbursement status of newly approved medical products is subject to significant uncertainty.", "sentB": "In general, under Section 382 of the Internal Revenue Code of 1986, as amended (the Code), a corporation that undergoes an ownership change is subject to limitations on its ability to utilize its pre-change NOLs to offset future taxable income.", "type": 1, "words": ["<tag1>", "The", "reimbursement", "status", "of", "newly", "approved", "medical", "products", "is", "subject", "to", "significant", "uncertainty.", "<tag2>", "In", "general,", "under", "Section", "382", "of", "the", "Internal", "Revenue", "Code", "of", "1986,", "as", "amended", "(the", "Code),", "a", "corporation", "that", "undergoes", "an", "ownership", "change", "is", "subject", "to", "limitations", "on", "its", "ability", "to", "utilize", "its", "pre-change", "NOLs", "to", "offset", "future", "taxable", "income.", "<tag3>"], "wordsA": ["The", "reimbursement", "status", "of", "newly", "approved", "medical", "products", "is", "subject", "to", "significant", "uncertainty."], "wordsB": ["In", "general,", "under", "Section", "382", "of", "the", "Internal", "Revenue", "Code", "of", "1986,", "as", "amended", "(the", "Code),", "a", "corporation", "that", "undergoes", "an", "ownership", "change", "is", "subject", "to", "limitations", "on", "its", "ability", "to", "utilize", "its", "pre-change", "NOLs", "to", "offset", "future", "taxable", "income."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p3_s1", "idA": "749647_12_item1a_p43_s0", "sentA": "The commercial potential of a drug candidate in development is difficult to predict.", "sentB": "Our lead drug candidate failed to meets its primary endpoint in the Phase III HEAT study.", "type": 1, "words": ["<tag1>", "The", "commercial", "potential", "of", "a", "drug", "candidate", "in", "development", "is", "difficult", "to", "predict.", "<tag2>", "Our", "lead", "drug", "candidate", "failed", "to", "meets", "its", "primary", "endpoint", "in", "the", "Phase", "III", "HEAT", "study.", "<tag3>"], "wordsA": ["The", "commercial", "potential", "of", "a", "drug", "candidate", "in", "development", "is", "difficult", "to", "predict."], "wordsB": ["Our", "lead", "drug", "candidate", "failed", "to", "meets", "its", "primary", "endpoint", "in", "the", "Phase", "III", "HEAT", "study."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p56_s1", "idA": "749647_12_item1a_p49_s3", "sentA": "Further, we do not carry key man insurance on any of our personnel.", "sentB": "If we do pursue such a strategy, we could, among other things:", "type": 1, "words": ["<tag1>", "Further,", "we", "do", "not", "carry", "key", "man", "insurance", "on", "any", "of", "our", "personnel.", "<tag2>", "If", "we", "do", "pursue", "such", "a", "strategy,", "we", "could,", "among", "other", "things:", "<tag3>"], "wordsA": ["Further,", "we", "do", "not", "carry", "key", "man", "insurance", "on", "any", "of", "our", "personnel."], "wordsB": ["If", "we", "do", "pursue", "such", "a", "strategy,", "we", "could,", "among", "other", "things:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p5_s0", "idA": "749647_12_item1a_p49_s4", "sentA": "Therefore, loss of the services of key personnel would not be ameliorated by the receipt of the proceeds from such insurance.", "sentB": "On January 31, 2013, we announced that our lead product ThermoDox in combination with radiofrequency ablation failed to meet the primary endpoint of the Phase III clinical trial for primary liver cancer (the HEAT study).", "type": 1, "words": ["<tag1>", "Therefore,", "loss", "of", "the", "services", "of", "key", "personnel", "would", "not", "be", "ameliorated", "by", "the", "receipt", "of", "the", "proceeds", "from", "such", "insurance.", "<tag2>", "On", "January", "31,", "2013,", "we", "announced", "that", "our", "lead", "product", "ThermoDox", "in", "combination", "with", "radiofrequency", "ablation", "failed", "to", "meet", "the", "primary", "endpoint", "of", "the", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "HEAT", "study).", "<tag3>"], "wordsA": ["Therefore,", "loss", "of", "the", "services", "of", "key", "personnel", "would", "not", "be", "ameliorated", "by", "the", "receipt", "of", "the", "proceeds", "from", "such", "insurance."], "wordsB": ["On", "January", "31,", "2013,", "we", "announced", "that", "our", "lead", "product", "ThermoDox", "in", "combination", "with", "radiofrequency", "ablation", "failed", "to", "meet", "the", "primary", "endpoint", "of", "the", "Phase", "III", "clinical", "trial", "for", "primary", "liver", "cancer", "(the", "HEAT", "study)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p10_s3", "idA": "749647_12_item1a_p4_s2", "sentA": "It will take us several years to complete clinical studies.", "sentB": "ThermoDox is currently also being evaluated in Phase II clinical trials and other preclinical studies.", "type": 1, "words": ["<tag1>", "It", "will", "take", "us", "several", "years", "to", "complete", "clinical", "studies.", "<tag2>", "ThermoDox", "is", "currently", "also", "being", "evaluated", "in", "Phase", "II", "clinical", "trials", "and", "other", "preclinical", "studies.", "<tag3>"], "wordsA": ["It", "will", "take", "us", "several", "years", "to", "complete", "clinical", "studies."], "wordsB": ["ThermoDox", "is", "currently", "also", "being", "evaluated", "in", "Phase", "II", "clinical", "trials", "and", "other", "preclinical", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p5_s2", "idA": "749647_12_item1a_p4_s2", "sentA": "It will take us several years to complete clinical studies.", "sentB": "ThermoDox is also being evaluated in a Phase II clinical trial for colorectal liver metastasis, a Phase II clinical trial for recurrent chest wall breast cancer and other preclinical studies.", "type": 1, "words": ["<tag1>", "It", "will", "take", "us", "several", "years", "to", "complete", "clinical", "studies.", "<tag2>", "ThermoDox", "is", "also", "being", "evaluated", "in", "a", "Phase", "II", "clinical", "trial", "for", "colorectal", "liver", "metastasis,", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "and", "other", "preclinical", "studies.", "<tag3>"], "wordsA": ["It", "will", "take", "us", "several", "years", "to", "complete", "clinical", "studies."], "wordsB": ["ThermoDox", "is", "also", "being", "evaluated", "in", "a", "Phase", "II", "clinical", "trial", "for", "colorectal", "liver", "metastasis,", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "and", "other", "preclinical", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p65_s2", "idA": "749647_12_item1a_p4_s4", "sentA": "The failure of one or more of our drug candidates could have a material adverse effect on our business, financial condition and results of operations.", "sentB": "The failure of the HEAT study to demonstrate clinical effectiveness, in addition to general market conditions, may make it very difficult for us to seek financing from the capital markets.", "type": 1, "words": ["<tag1>", "The", "failure", "of", "one", "or", "more", "of", "our", "drug", "candidates", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations.", "<tag2>", "The", "failure", "of", "the", "HEAT", "study", "to", "demonstrate", "clinical", "effectiveness,", "in", "addition", "to", "general", "market", "conditions,", "may", "make", "it", "very", "difficult", "for", "us", "to", "seek", "financing", "from", "the", "capital", "markets.", "<tag3>"], "wordsA": ["The", "failure", "of", "one", "or", "more", "of", "our", "drug", "candidates", "could", "have", "a", "material", "adverse", "effect", "on", "our", "business,", "financial", "condition", "and", "results", "of", "operations."], "wordsB": ["The", "failure", "of", "the", "HEAT", "study", "to", "demonstrate", "clinical", "effectiveness,", "in", "addition", "to", "general", "market", "conditions,", "may", "make", "it", "very", "difficult", "for", "us", "to", "seek", "financing", "from", "the", "capital", "markets."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p19_s3", "idA": "749647_12_item1a_p53_s1", "sentA": "We believe that the level of interest by others in investigating the potential of possible competitive treatments and alternative technologies will continue and may increase.", "sentB": "Additionally, we have a joint research agreement with Philips Healthcare, a division of Royal Philips Electronics, to evaluate the combination of Philips high intensity focused ultrasound (HIFU) with ThermoDox to determine the potential of this combination to treat a broad range of cancers.", "type": 1, "words": ["<tag1>", "We", "believe", "that", "the", "level", "of", "interest", "by", "others", "in", "investigating", "the", "potential", "of", "possible", "competitive", "treatments", "and", "alternative", "technologies", "will", "continue", "and", "may", "increase.", "<tag2>", "Additionally,", "we", "have", "a", "joint", "research", "agreement", "with", "Philips", "Healthcare,", "a", "division", "of", "Royal", "Philips", "Electronics,", "to", "evaluate", "the", "combination", "of", "Philips", "high", "intensity", "focused", "ultrasound", "(HIFU)", "with", "ThermoDox", "to", "determine", "the", "potential", "of", "this", "combination", "to", "treat", "a", "broad", "range", "of", "cancers.", "<tag3>"], "wordsA": ["We", "believe", "that", "the", "level", "of", "interest", "by", "others", "in", "investigating", "the", "potential", "of", "possible", "competitive", "treatments", "and", "alternative", "technologies", "will", "continue", "and", "may", "increase."], "wordsB": ["Additionally,", "we", "have", "a", "joint", "research", "agreement", "with", "Philips", "Healthcare,", "a", "division", "of", "Royal", "Philips", "Electronics,", "to", "evaluate", "the", "combination", "of", "Philips", "high", "intensity", "focused", "ultrasound", "(HIFU)", "with", "ThermoDox", "to", "determine", "the", "potential", "of", "this", "combination", "to", "treat", "a", "broad", "range", "of", "cancers."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p72_s1", "idA": "749647_12_item1a_p61_s1", "sentA": "On May 10, 2011, we received a letter from NASDAQ stating that our MVLS had been $35 million or greater for the previous ten consecutive business days (from April 26, 2011 to May 9, 2011) and that we had regained compliance with the Rule.", "sentB": "As of March 15, 2013, we had 50,832,933 shares of common stock outstanding, all of which shares, other than shares held by our directors and certain officers, were eligible for sale in the public market, subject in some cases to compliance with the requirements of Rule 144, including the volume limitations and manner of sale requirements.", "type": 1, "words": ["<tag1>", "On", "May", "10,", "2011,", "we", "received", "a", "letter", "from", "NASDAQ", "stating", "that", "our", "MVLS", "had", "been", "$35", "million", "or", "greater", "for", "the", "previous", "ten", "consecutive", "business", "days", "(from", "April", "26,", "2011", "to", "May", "9,", "2011)", "and", "that", "we", "had", "regained", "compliance", "with", "the", "Rule.", "<tag2>", "As", "of", "March", "15,", "2013,", "we", "had", "50,832,933", "shares", "of", "common", "stock", "outstanding,", "all", "of", "which", "shares,", "other", "than", "shares", "held", "by", "our", "directors", "and", "certain", "officers,", "were", "eligible", "for", "sale", "in", "the", "public", "market,", "subject", "in", "some", "cases", "to", "compliance", "with", "the", "requirements", "of", "Rule", "144,", "including", "the", "volume", "limitations", "and", "manner", "of", "sale", "requirements.", "<tag3>"], "wordsA": ["On", "May", "10,", "2011,", "we", "received", "a", "letter", "from", "NASDAQ", "stating", "that", "our", "MVLS", "had", "been", "$35", "million", "or", "greater", "for", "the", "previous", "ten", "consecutive", "business", "days", "(from", "April", "26,", "2011", "to", "May", "9,", "2011)", "and", "that", "we", "had", "regained", "compliance", "with", "the", "Rule."], "wordsB": ["As", "of", "March", "15,", "2013,", "we", "had", "50,832,933", "shares", "of", "common", "stock", "outstanding,", "all", "of", "which", "shares,", "other", "than", "shares", "held", "by", "our", "directors", "and", "certain", "officers,", "were", "eligible", "for", "sale", "in", "the", "public", "market,", "subject", "in", "some", "cases", "to", "compliance", "with", "the", "requirements", "of", "Rule", "144,", "including", "the", "volume", "limitations", "and", "manner", "of", "sale", "requirements."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_13_item1a_p13_s2", "idA": "749647_12_item1a_p64_s3", "sentA": "For example, recently credit spreads have widened considerably.", "sentB": "For example, ThermoDox is being evaluated in a Phase II clinical trial for colorectal liver metastasis, a Phase II clinical trial for recurrent chest wall breast cancer and other preclinical studies.", "type": 1, "words": ["<tag1>", "For", "example,", "recently", "credit", "spreads", "have", "widened", "considerably.", "<tag2>", "For", "example,", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "II", "clinical", "trial", "for", "colorectal", "liver", "metastasis,", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "and", "other", "preclinical", "studies.", "<tag3>"], "wordsA": ["For", "example,", "recently", "credit", "spreads", "have", "widened", "considerably."], "wordsB": ["For", "example,", "ThermoDox", "is", "being", "evaluated", "in", "a", "Phase", "II", "clinical", "trial", "for", "colorectal", "liver", "metastasis,", "a", "Phase", "II", "clinical", "trial", "for", "recurrent", "chest", "wall", "breast", "cancer", "and", "other", "preclinical", "studies."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item1a_p81_s0", "idA": "749647_13_item1a_p10_s2", "sentA": "Following our announcement on January 31, 2013 that the HEAT study failed to meet its primary endpoint of progression free survival, we will continue to follow the patients enrolled in the Heat study to the secondary endpoint, overall survival.", "sentB": "Other companies have found that the increased stock prices resulting from reverse splits tend to diminish over time unless supported by positive developments in the business.", "type": 1, "words": ["<tag1>", "Following", "our", "announcement", "on", "January", "31,", "2013", "that", "the", "HEAT", "study", "failed", "to", "meet", "its", "primary", "endpoint", "of", "progression", "free", "survival,", "we", "will", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "Heat", "study", "to", "the", "secondary", "endpoint,", "overall", "survival.", "<tag2>", "Other", "companies", "have", "found", "that", "the", "increased", "stock", "prices", "resulting", "from", "reverse", "splits", "tend", "to", "diminish", "over", "time", "unless", "supported", "by", "positive", "developments", "in", "the", "business.", "<tag3>"], "wordsA": ["Following", "our", "announcement", "on", "January", "31,", "2013", "that", "the", "HEAT", "study", "failed", "to", "meet", "its", "primary", "endpoint", "of", "progression", "free", "survival,", "we", "will", "continue", "to", "follow", "the", "patients", "enrolled", "in", "the", "Heat", "study", "to", "the", "secondary", "endpoint,", "overall", "survival."], "wordsB": ["Other", "companies", "have", "found", "that", "the", "increased", "stock", "prices", "resulting", "from", "reverse", "splits", "tend", "to", "diminish", "over", "time", "unless", "supported", "by", "positive", "developments", "in", "the", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item1a_p30_s0", "idA": "749647_13_item1a_p30_s0", "sentA": "The FDA and foreign regulatory agencies require that the safety and efficacy of product candidates be supported through adequate and well-controlled clinical trials.", "sentB": "The FDA requires clinical trials to be conducted in accordance with good clinical practices, including for conducting, recording and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity and confidentiality of clinical trial participants are protected.", "type": 1, "words": ["<tag1>", "The", "FDA", "and", "foreign", "regulatory", "agencies", "require", "that", "the", "safety", "and", "efficacy", "of", "product", "candidates", "be", "supported", "through", "adequate", "and", "well-controlled", "clinical", "trials.", "<tag2>", "The", "FDA", "requires", "clinical", "trials", "to", "be", "conducted", "in", "accordance", "with", "good", "clinical", "practices,", "including", "for", "conducting,", "recording", "and", "reporting", "the", "results", "of", "clinical", "trials", "to", "assure", "that", "data", "and", "reported", "results", "are", "credible", "and", "accurate", "and", "that", "the", "rights,", "integrity", "and", "confidentiality", "of", "clinical", "trial", "participants", "are", "protected.", "<tag3>"], "wordsA": ["The", "FDA", "and", "foreign", "regulatory", "agencies", "require", "that", "the", "safety", "and", "efficacy", "of", "product", "candidates", "be", "supported", "through", "adequate", "and", "well-controlled", "clinical", "trials."], "wordsB": ["The", "FDA", "requires", "clinical", "trials", "to", "be", "conducted", "in", "accordance", "with", "good", "clinical", "practices,", "including", "for", "conducting,", "recording", "and", "reporting", "the", "results", "of", "clinical", "trials", "to", "assure", "that", "data", "and", "reported", "results", "are", "credible", "and", "accurate", "and", "that", "the", "rights,", "integrity", "and", "confidentiality", "of", "clinical", "trial", "participants", "are", "protected."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item1a_p67_s0", "idA": "749647_13_item1a_p31_s0", "sentA": "We are subject to the periodic inspection of our clinical trials, facilities, procedures and operations and/or the testing of our products by the FDA to determine whether our systems and processes, or those of our vendors and suppliers, are in compliance with FDA regulations.", "sentB": "Despite the implementation of security measures, our internal computer systems and those of our CROs and other contractors and consultants are vulnerable to damage from computer viruses, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures.", "type": 1, "words": ["<tag1>", "We", "are", "subject", "to", "the", "periodic", "inspection", "of", "our", "clinical", "trials,", "facilities,", "procedures", "and", "operations", "and/or", "the", "testing", "of", "our", "products", "by", "the", "FDA", "to", "determine", "whether", "our", "systems", "and", "processes,", "or", "those", "of", "our", "vendors", "and", "suppliers,", "are", "in", "compliance", "with", "FDA", "regulations.", "<tag2>", "Despite", "the", "implementation", "of", "security", "measures,", "our", "internal", "computer", "systems", "and", "those", "of", "our", "CROs", "and", "other", "contractors", "and", "consultants", "are", "vulnerable", "to", "damage", "from", "computer", "viruses,", "unauthorized", "access,", "natural", "disasters,", "terrorism,", "war", "and", "telecommunication", "and", "electrical", "failures.", "<tag3>"], "wordsA": ["We", "are", "subject", "to", "the", "periodic", "inspection", "of", "our", "clinical", "trials,", "facilities,", "procedures", "and", "operations", "and/or", "the", "testing", "of", "our", "products", "by", "the", "FDA", "to", "determine", "whether", "our", "systems", "and", "processes,", "or", "those", "of", "our", "vendors", "and", "suppliers,", "are", "in", "compliance", "with", "FDA", "regulations."], "wordsB": ["Despite", "the", "implementation", "of", "security", "measures,", "our", "internal", "computer", "systems", "and", "those", "of", "our", "CROs", "and", "other", "contractors", "and", "consultants", "are", "vulnerable", "to", "damage", "from", "computer", "viruses,", "unauthorized", "access,", "natural", "disasters,", "terrorism,", "war", "and", "telecommunication", "and", "electrical", "failures."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item1a_p15_s1", "idA": "749647_13_item1a_p45_s0", "sentA": "The commercial success of our products will depend upon their acceptance by the medical community and third-party payers as clinically useful, cost effective and safe.", "sentB": "Our future capital requirements will depend upon numerous unpredictable factors, including, without limitation, the cost, timing, progress and outcomes of clinical studies and regulatory reviews of our proprietary drug candidates, our efforts to implement new collaborations, licenses and strategic transactions, general and administrative expenses, capital expenditures and other unforeseen uses of cash.", "type": 1, "words": ["<tag1>", "The", "commercial", "success", "of", "our", "products", "will", "depend", "upon", "their", "acceptance", "by", "the", "medical", "community", "and", "third-party", "payers", "as", "clinically", "useful,", "cost", "effective", "and", "safe.", "<tag2>", "Our", "future", "capital", "requirements", "will", "depend", "upon", "numerous", "unpredictable", "factors,", "including,", "without", "limitation,", "the", "cost,", "timing,", "progress", "and", "outcomes", "of", "clinical", "studies", "and", "regulatory", "reviews", "of", "our", "proprietary", "drug", "candidates,", "our", "efforts", "to", "implement", "new", "collaborations,", "licenses", "and", "strategic", "transactions,", "general", "and", "administrative", "expenses,", "capital", "expenditures", "and", "other", "unforeseen", "uses", "of", "cash.", "<tag3>"], "wordsA": ["The", "commercial", "success", "of", "our", "products", "will", "depend", "upon", "their", "acceptance", "by", "the", "medical", "community", "and", "third-party", "payers", "as", "clinically", "useful,", "cost", "effective", "and", "safe."], "wordsB": ["Our", "future", "capital", "requirements", "will", "depend", "upon", "numerous", "unpredictable", "factors,", "including,", "without", "limitation,", "the", "cost,", "timing,", "progress", "and", "outcomes", "of", "clinical", "studies", "and", "regulatory", "reviews", "of", "our", "proprietary", "drug", "candidates,", "our", "efforts", "to", "implement", "new", "collaborations,", "licenses", "and", "strategic", "transactions,", "general", "and", "administrative", "expenses,", "capital", "expenditures", "and", "other", "unforeseen", "uses", "of", "cash."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item1a_p1_s1", "idA": "749647_13_item1a_p83_s1", "sentA": "In general, under Section 382 of the Internal Revenue Code of 1986, as amended (the Code), a corporation that undergoes an ownership change is subject to limitations on its ability to utilize its pre-change NOLs to offset future taxable income.", "sentB": "We note these factors for investors as permitted by Section 21E of the Securities Exchange Act of 1934, as amended (Exchange Act), and Section 27A of the Securities Act of 1933, as amended (Securities Act).", "type": 1, "words": ["<tag1>", "In", "general,", "under", "Section", "382", "of", "the", "Internal", "Revenue", "Code", "of", "1986,", "as", "amended", "(the", "Code),", "a", "corporation", "that", "undergoes", "an", "ownership", "change", "is", "subject", "to", "limitations", "on", "its", "ability", "to", "utilize", "its", "pre-change", "NOLs", "to", "offset", "future", "taxable", "income.", "<tag2>", "We", "note", "these", "factors", "for", "investors", "as", "permitted", "by", "Section", "21E", "of", "the", "Securities", "Exchange", "Act", "of", "1934,", "as", "amended", "(Exchange", "Act),", "and", "Section", "27A", "of", "the", "Securities", "Act", "of", "1933,", "as", "amended", "(Securities", "Act).", "<tag3>"], "wordsA": ["In", "general,", "under", "Section", "382", "of", "the", "Internal", "Revenue", "Code", "of", "1986,", "as", "amended", "(the", "Code),", "a", "corporation", "that", "undergoes", "an", "ownership", "change", "is", "subject", "to", "limitations", "on", "its", "ability", "to", "utilize", "its", "pre-change", "NOLs", "to", "offset", "future", "taxable", "income."], "wordsB": ["We", "note", "these", "factors", "for", "investors", "as", "permitted", "by", "Section", "21E", "of", "the", "Securities", "Exchange", "Act", "of", "1934,", "as", "amended", "(Exchange", "Act),", "and", "Section", "27A", "of", "the", "Securities", "Act", "of", "1933,", "as", "amended", "(Securities", "Act)."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_14_item1a_p18_s2", "idA": "749647_13_item1a_p86_s2", "sentA": "We currently intend to retain all available funds and any future earnings to fund the development and growth of our business.", "sentB": "These transactions would entail numerous operational and financial risks, including exposure to unknown liabilities, disruption of our business and diversion of our management s time and attention in order to manage a collaboration or develop acquired products, product candidates or technologies, incurrence of substantial debt or dilutive issuances of equity securities to pay transaction consideration or costs, higher than expected collaboration, acquisition or integration costs, write-downs of assets or goodwill or impairment charges, increased amortization expenses, difficulty and cost in facilitating the collaboration or combining the operations and personnel of any acquired business, impairment of relationships with key suppliers, manufacturers or customers of any acquired business due to changes in management and ownership and the inability to retain key employees of any acquired business.", "type": 1, "words": ["<tag1>", "We", "currently", "intend", "to", "retain", "all", "available", "funds", "and", "any", "future", "earnings", "to", "fund", "the", "development", "and", "growth", "of", "our", "business.", "<tag2>", "These", "transactions", "would", "entail", "numerous", "operational", "and", "financial", "risks,", "including", "exposure", "to", "unknown", "liabilities,", "disruption", "of", "our", "business", "and", "diversion", "of", "our", "management", "s", "time", "and", "attention", "in", "order", "to", "manage", "a", "collaboration", "or", "develop", "acquired", "products,", "product", "candidates", "or", "technologies,", "incurrence", "of", "substantial", "debt", "or", "dilutive", "issuances", "of", "equity", "securities", "to", "pay", "transaction", "consideration", "or", "costs,", "higher", "than", "expected", "collaboration,", "acquisition", "or", "integration", "costs,", "write-downs", "of", "assets", "or", "goodwill", "or", "impairment", "charges,", "increased", "amortization", "expenses,", "difficulty", "and", "cost", "in", "facilitating", "the", "collaboration", "or", "combining", "the", "operations", "and", "personnel", "of", "any", "acquired", "business,", "impairment", "of", "relationships", "with", "key", "suppliers,", "manufacturers", "or", "customers", "of", "any", "acquired", "business", "due", "to", "changes", "in", "management", "and", "ownership", "and", "the", "inability", "to", "retain", "key", "employees", "of", "any", "acquired", "business.", "<tag3>"], "wordsA": ["We", "currently", "intend", "to", "retain", "all", "available", "funds", "and", "any", "future", "earnings", "to", "fund", "the", "development", "and", "growth", "of", "our", "business."], "wordsB": ["These", "transactions", "would", "entail", "numerous", "operational", "and", "financial", "risks,", "including", "exposure", "to", "unknown", "liabilities,", "disruption", "of", "our", "business", "and", "diversion", "of", "our", "management", "s", "time", "and", "attention", "in", "order", "to", "manage", "a", "collaboration", "or", "develop", "acquired", "products,", "product", "candidates", "or", "technologies,", "incurrence", "of", "substantial", "debt", "or", "dilutive", "issuances", "of", "equity", "securities", "to", "pay", "transaction", "consideration", "or", "costs,", "higher", "than", "expected", "collaboration,", "acquisition", "or", "integration", "costs,", "write-downs", "of", "assets", "or", "goodwill", "or", "impairment", "charges,", "increased", "amortization", "expenses,", "difficulty", "and", "cost", "in", "facilitating", "the", "collaboration", "or", "combining", "the", "operations", "and", "personnel", "of", "any", "acquired", "business,", "impairment", "of", "relationships", "with", "key", "suppliers,", "manufacturers", "or", "customers", "of", "any", "acquired", "business", "due", "to", "changes", "in", "management", "and", "ownership", "and", "the", "inability", "to", "retain", "key", "employees", "of", "any", "acquired", "business."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item1a_p26_s0", "idA": "749647_14_item1a_p15_s3", "sentA": "We may need to pursue dilutive equity financings, such as the issuance of shares of common stock, convertible debt or other convertible or exercisable securities.", "sentB": "Strategic transactions, such as acquisitions, partnerships and collaborations, including the EGEN acquisition, involve numerous risks, including:", "type": 1, "words": ["<tag1>", "We", "may", "need", "to", "pursue", "dilutive", "equity", "financings,", "such", "as", "the", "issuance", "of", "shares", "of", "common", "stock,", "convertible", "debt", "or", "other", "convertible", "or", "exercisable", "securities.", "<tag2>", "Strategic", "transactions,", "such", "as", "acquisitions,", "partnerships", "and", "collaborations,", "including", "the", "EGEN", "acquisition,", "involve", "numerous", "risks,", "including:", "<tag3>"], "wordsA": ["We", "may", "need", "to", "pursue", "dilutive", "equity", "financings,", "such", "as", "the", "issuance", "of", "shares", "of", "common", "stock,", "convertible", "debt", "or", "other", "convertible", "or", "exercisable", "securities."], "wordsB": ["Strategic", "transactions,", "such", "as", "acquisitions,", "partnerships", "and", "collaborations,", "including", "the", "EGEN", "acquisition,", "involve", "numerous", "risks,", "including:"], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item1a_p34_s0", "idA": "749647_14_item1a_p15_s3", "sentA": "We may need to pursue dilutive equity financings, such as the issuance of shares of common stock, convertible debt or other convertible or exercisable securities.", "sentB": "The patent positions of pharmaceutical and biotechnology companies, such as ours, are uncertain and involve complex legal and factual issues.", "type": 1, "words": ["<tag1>", "We", "may", "need", "to", "pursue", "dilutive", "equity", "financings,", "such", "as", "the", "issuance", "of", "shares", "of", "common", "stock,", "convertible", "debt", "or", "other", "convertible", "or", "exercisable", "securities.", "<tag2>", "The", "patent", "positions", "of", "pharmaceutical", "and", "biotechnology", "companies,", "such", "as", "ours,", "are", "uncertain", "and", "involve", "complex", "legal", "and", "factual", "issues.", "<tag3>"], "wordsA": ["We", "may", "need", "to", "pursue", "dilutive", "equity", "financings,", "such", "as", "the", "issuance", "of", "shares", "of", "common", "stock,", "convertible", "debt", "or", "other", "convertible", "or", "exercisable", "securities."], "wordsB": ["The", "patent", "positions", "of", "pharmaceutical", "and", "biotechnology", "companies,", "such", "as", "ours,", "are", "uncertain", "and", "involve", "complex", "legal", "and", "factual", "issues."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item1a_p36_s0", "idA": "749647_14_item1a_p1_s4", "sentA": "Moreover, we operate in a competitive and rapidly changing environment.", "sentB": "The coverage claimed in a patent application can be significantly reduced before the patent is issued.", "type": 1, "words": ["<tag1>", "Moreover,", "we", "operate", "in", "a", "competitive", "and", "rapidly", "changing", "environment.", "<tag2>", "The", "coverage", "claimed", "in", "a", "patent", "application", "can", "be", "significantly", "reduced", "before", "the", "patent", "is", "issued.", "<tag3>"], "wordsA": ["Moreover,", "we", "operate", "in", "a", "competitive", "and", "rapidly", "changing", "environment."], "wordsB": ["The", "coverage", "claimed", "in", "a", "patent", "application", "can", "be", "significantly", "reduced", "before", "the", "patent", "is", "issued."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item1a_p68_s3", "idA": "749647_14_item1a_p26_s0", "sentA": "There may be third party patents that relate to our products and technology.", "sentB": "Market acceptance depends upon physicians and hospitals obtaining adequate reimbursement rates from third-party payors to make our products commercially viable.", "type": 1, "words": ["<tag1>", "There", "may", "be", "third", "party", "patents", "that", "relate", "to", "our", "products", "and", "technology.", "<tag2>", "Market", "acceptance", "depends", "upon", "physicians", "and", "hospitals", "obtaining", "adequate", "reimbursement", "rates", "from", "third-party", "payors", "to", "make", "our", "products", "commercially", "viable.", "<tag3>"], "wordsA": ["There", "may", "be", "third", "party", "patents", "that", "relate", "to", "our", "products", "and", "technology."], "wordsB": ["Market", "acceptance", "depends", "upon", "physicians", "and", "hospitals", "obtaining", "adequate", "reimbursement", "rates", "from", "third-party", "payors", "to", "make", "our", "products", "commercially", "viable."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item1a_p28_s0", "idA": "749647_14_item1a_p26_s1", "sentA": "We may unintentionally infringe upon valid patent rights of third parties.", "sentB": "We may never realize the perceived benefits of the EGEN acquisition or potential future transactions.", "type": 1, "words": ["<tag1>", "We", "may", "unintentionally", "infringe", "upon", "valid", "patent", "rights", "of", "third", "parties.", "<tag2>", "We", "may", "never", "realize", "the", "perceived", "benefits", "of", "the", "EGEN", "acquisition", "or", "potential", "future", "transactions.", "<tag3>"], "wordsA": ["We", "may", "unintentionally", "infringe", "upon", "valid", "patent", "rights", "of", "third", "parties."], "wordsB": ["We", "may", "never", "realize", "the", "perceived", "benefits", "of", "the", "EGEN", "acquisition", "or", "potential", "future", "transactions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item1a_p34_s3", "idA": "749647_14_item1a_p28_s1", "sentA": "Because we do not have the ability to conduct our own clinical trials, we must rely on the efforts of others and have limited control over, and cannot predict accurately, the timing of such trials, the costs associated with such trials or the procedures that are followed for such trials.", "sentB": "Even for patents that are held valid and enforceable, the legal process associated with obtaining such a judgment is time consuming and costly.", "type": 1, "words": ["<tag1>", "Because", "we", "do", "not", "have", "the", "ability", "to", "conduct", "our", "own", "clinical", "trials,", "we", "must", "rely", "on", "the", "efforts", "of", "others", "and", "have", "limited", "control", "over,", "and", "cannot", "predict", "accurately,", "the", "timing", "of", "such", "trials,", "the", "costs", "associated", "with", "such", "trials", "or", "the", "procedures", "that", "are", "followed", "for", "such", "trials.", "<tag2>", "Even", "for", "patents", "that", "are", "held", "valid", "and", "enforceable,", "the", "legal", "process", "associated", "with", "obtaining", "such", "a", "judgment", "is", "time", "consuming", "and", "costly.", "<tag3>"], "wordsA": ["Because", "we", "do", "not", "have", "the", "ability", "to", "conduct", "our", "own", "clinical", "trials,", "we", "must", "rely", "on", "the", "efforts", "of", "others", "and", "have", "limited", "control", "over,", "and", "cannot", "predict", "accurately,", "the", "timing", "of", "such", "trials,", "the", "costs", "associated", "with", "such", "trials", "or", "the", "procedures", "that", "are", "followed", "for", "such", "trials."], "wordsB": ["Even", "for", "patents", "that", "are", "held", "valid", "and", "enforceable,", "the", "legal", "process", "associated", "with", "obtaining", "such", "a", "judgment", "is", "time", "consuming", "and", "costly."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item1a_p27_s0", "idA": "749647_14_item1a_p2_s0", "sentA": "We have a history of significant losses from operations and expect to continue to incur significant losses for the foreseeable future.", "sentB": "the incurrence of significant exit charges if products or technologies acquired in business combinations are unsuccessful.", "type": 1, "words": ["<tag1>", "We", "have", "a", "history", "of", "significant", "losses", "from", "operations", "and", "expect", "to", "continue", "to", "incur", "significant", "losses", "for", "the", "foreseeable", "future.", "<tag2>", "the", "incurrence", "of", "significant", "exit", "charges", "if", "products", "or", "technologies", "acquired", "in", "business", "combinations", "are", "unsuccessful.", "<tag3>"], "wordsA": ["We", "have", "a", "history", "of", "significant", "losses", "from", "operations", "and", "expect", "to", "continue", "to", "incur", "significant", "losses", "for", "the", "foreseeable", "future."], "wordsB": ["the", "incurrence", "of", "significant", "exit", "charges", "if", "products", "or", "technologies", "acquired", "in", "business", "combinations", "are", "unsuccessful."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item1a_p19_s1", "idA": "749647_14_item1a_p44_s4", "sentA": "These actual and potential changes are causing the marketplace to put increased emphasis on the delivery of more cost-effective treatments.", "sentB": "The acquisition included EGEN s Phase Ib DNA-based immunotherapy product candidate GEN-1 (formerly known as EGEN-001) and its therapeutic platform technologies, TheraPlas for delivery of DNA and mRNA, and TheraSilence for delivery of RNA.", "type": 1, "words": ["<tag1>", "These", "actual", "and", "potential", "changes", "are", "causing", "the", "marketplace", "to", "put", "increased", "emphasis", "on", "the", "delivery", "of", "more", "cost-effective", "treatments.", "<tag2>", "The", "acquisition", "included", "EGEN", "s", "Phase", "Ib", "DNA-based", "immunotherapy", "product", "candidate", "GEN-1", "(formerly", "known", "as", "EGEN-001)", "and", "its", "therapeutic", "platform", "technologies,", "TheraPlas", "for", "delivery", "of", "DNA", "and", "mRNA,", "and", "TheraSilence", "for", "delivery", "of", "RNA.", "<tag3>"], "wordsA": ["These", "actual", "and", "potential", "changes", "are", "causing", "the", "marketplace", "to", "put", "increased", "emphasis", "on", "the", "delivery", "of", "more", "cost-effective", "treatments."], "wordsB": ["The", "acquisition", "included", "EGEN", "s", "Phase", "Ib", "DNA-based", "immunotherapy", "product", "candidate", "GEN-1", "(formerly", "known", "as", "EGEN-001)", "and", "its", "therapeutic", "platform", "technologies,", "TheraPlas", "for", "delivery", "of", "DNA", "and", "mRNA,", "and", "TheraSilence", "for", "delivery", "of", "RNA."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item1a_p22_s1", "idA": "749647_14_item1a_p63_s3", "sentA": "Most of our current and potential competitors have substantially greater financial, technical, human and other resources, and may also have far greater experience than do we, both in pre-clinical testing and human clinical trials of new products and in obtaining FDA and other regulatory approvals.", "sentB": "These costs and expenses include the incurrence of $5.0 million of new indebtedness and approximately $1.4 million in financial advisory, legal, accounting, consulting and other advisory fees and expenses, reorganization and restructuring costs, severance/employee benefit-related expenses, filing fees, printing expenses and other related charges.", "type": 1, "words": ["<tag1>", "Most", "of", "our", "current", "and", "potential", "competitors", "have", "substantially", "greater", "financial,", "technical,", "human", "and", "other", "resources,", "and", "may", "also", "have", "far", "greater", "experience", "than", "do", "we,", "both", "in", "pre-clinical", "testing", "and", "human", "clinical", "trials", "of", "new", "products", "and", "in", "obtaining", "FDA", "and", "other", "regulatory", "approvals.", "<tag2>", "These", "costs", "and", "expenses", "include", "the", "incurrence", "of", "$5.0", "million", "of", "new", "indebtedness", "and", "approximately", "$1.4", "million", "in", "financial", "advisory,", "legal,", "accounting,", "consulting", "and", "other", "advisory", "fees", "and", "expenses,", "reorganization", "and", "restructuring", "costs,", "severance/employee", "benefit-related", "expenses,", "filing", "fees,", "printing", "expenses", "and", "other", "related", "charges.", "<tag3>"], "wordsA": ["Most", "of", "our", "current", "and", "potential", "competitors", "have", "substantially", "greater", "financial,", "technical,", "human", "and", "other", "resources,", "and", "may", "also", "have", "far", "greater", "experience", "than", "do", "we,", "both", "in", "pre-clinical", "testing", "and", "human", "clinical", "trials", "of", "new", "products", "and", "in", "obtaining", "FDA", "and", "other", "regulatory", "approvals."], "wordsB": ["These", "costs", "and", "expenses", "include", "the", "incurrence", "of", "$5.0", "million", "of", "new", "indebtedness", "and", "approximately", "$1.4", "million", "in", "financial", "advisory,", "legal,", "accounting,", "consulting", "and", "other", "advisory", "fees", "and", "expenses,", "reorganization", "and", "restructuring", "costs,", "severance/employee", "benefit-related", "expenses,", "filing", "fees,", "printing", "expenses", "and", "other", "related", "charges."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item1a_p19_s5", "idA": "749647_14_item1a_p64_s0", "sentA": "We may be subject to significant product liability claims and litigation.", "sentB": "The integration may be more difficult, costly or time consuming than expected.", "type": 1, "words": ["<tag1>", "We", "may", "be", "subject", "to", "significant", "product", "liability", "claims", "and", "litigation.", "<tag2>", "The", "integration", "may", "be", "more", "difficult,", "costly", "or", "time", "consuming", "than", "expected.", "<tag3>"], "wordsA": ["We", "may", "be", "subject", "to", "significant", "product", "liability", "claims", "and", "litigation."], "wordsB": ["The", "integration", "may", "be", "more", "difficult,", "costly", "or", "time", "consuming", "than", "expected."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item1a_p37_s0", "idA": "749647_14_item1a_p65_s2", "sentA": "If we were to be subject to a claim in excess of this coverage or to a claim not covered by our insurance and the claim succeeded, we would be required to pay the claim with our own limited resources, which could have a severe adverse effect on our business.", "sentB": "Since publication of discoveries in scientific or patent literature often lags behind the date of such discoveries, we cannot be certain that we were the first inventor of inventions covered by our patents or patent applications.", "type": 1, "words": ["<tag1>", "If", "we", "were", "to", "be", "subject", "to", "a", "claim", "in", "excess", "of", "this", "coverage", "or", "to", "a", "claim", "not", "covered", "by", "our", "insurance", "and", "the", "claim", "succeeded,", "we", "would", "be", "required", "to", "pay", "the", "claim", "with", "our", "own", "limited", "resources,", "which", "could", "have", "a", "severe", "adverse", "effect", "on", "our", "business.", "<tag2>", "Since", "publication", "of", "discoveries", "in", "scientific", "or", "patent", "literature", "often", "lags", "behind", "the", "date", "of", "such", "discoveries,", "we", "cannot", "be", "certain", "that", "we", "were", "the", "first", "inventor", "of", "inventions", "covered", "by", "our", "patents", "or", "patent", "applications.", "<tag3>"], "wordsA": ["If", "we", "were", "to", "be", "subject", "to", "a", "claim", "in", "excess", "of", "this", "coverage", "or", "to", "a", "claim", "not", "covered", "by", "our", "insurance", "and", "the", "claim", "succeeded,", "we", "would", "be", "required", "to", "pay", "the", "claim", "with", "our", "own", "limited", "resources,", "which", "could", "have", "a", "severe", "adverse", "effect", "on", "our", "business."], "wordsB": ["Since", "publication", "of", "discoveries", "in", "scientific", "or", "patent", "literature", "often", "lags", "behind", "the", "date", "of", "such", "discoveries,", "we", "cannot", "be", "certain", "that", "we", "were", "the", "first", "inventor", "of", "inventions", "covered", "by", "our", "patents", "or", "patent", "applications."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item1a_p38_s0", "idA": "749647_14_item1a_p68_s0", "sentA": "The market price of our common stock has been, and may continue to be volatile and fluctuate significantly, which could result in substantial losses for investors and subject us to securities class action litigation.", "sentB": "An adverse outcome in any judicial proceeding involving intellectual property, including patents, could subject us to significant liabilities to third parties, require disputed rights to be licensed from or to third parties or require us to cease using the technology in dispute.", "type": 1, "words": ["<tag1>", "The", "market", "price", "of", "our", "common", "stock", "has", "been,", "and", "may", "continue", "to", "be", "volatile", "and", "fluctuate", "significantly,", "which", "could", "result", "in", "substantial", "losses", "for", "investors", "and", "subject", "us", "to", "securities", "class", "action", "litigation.", "<tag2>", "An", "adverse", "outcome", "in", "any", "judicial", "proceeding", "involving", "intellectual", "property,", "including", "patents,", "could", "subject", "us", "to", "significant", "liabilities", "to", "third", "parties,", "require", "disputed", "rights", "to", "be", "licensed", "from", "or", "to", "third", "parties", "or", "require", "us", "to", "cease", "using", "the", "technology", "in", "dispute.", "<tag3>"], "wordsA": ["The", "market", "price", "of", "our", "common", "stock", "has", "been,", "and", "may", "continue", "to", "be", "volatile", "and", "fluctuate", "significantly,", "which", "could", "result", "in", "substantial", "losses", "for", "investors", "and", "subject", "us", "to", "securities", "class", "action", "litigation."], "wordsB": ["An", "adverse", "outcome", "in", "any", "judicial", "proceeding", "involving", "intellectual", "property,", "including", "patents,", "could", "subject", "us", "to", "significant", "liabilities", "to", "third", "parties,", "require", "disputed", "rights", "to", "be", "licensed", "from", "or", "to", "third", "parties", "or", "require", "us", "to", "cease", "using", "the", "technology", "in", "dispute."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item1a_p28_s3", "idA": "749647_14_item1a_p91_s3", "sentA": "In addition, our classified board of directors may discourage such transactions by increasing the amount of time necessary to obtain majority representation on our board of directors.", "sentB": "In addition, our effective tax rate for future periods could be negatively impacted by the EGEN acquisition or potential future transactions.", "type": 1, "words": ["<tag1>", "In", "addition,", "our", "classified", "board", "of", "directors", "may", "discourage", "such", "transactions", "by", "increasing", "the", "amount", "of", "time", "necessary", "to", "obtain", "majority", "representation", "on", "our", "board", "of", "directors.", "<tag2>", "In", "addition,", "our", "effective", "tax", "rate", "for", "future", "periods", "could", "be", "negatively", "impacted", "by", "the", "EGEN", "acquisition", "or", "potential", "future", "transactions.", "<tag3>"], "wordsA": ["In", "addition,", "our", "classified", "board", "of", "directors", "may", "discourage", "such", "transactions", "by", "increasing", "the", "amount", "of", "time", "necessary", "to", "obtain", "majority", "representation", "on", "our", "board", "of", "directors."], "wordsB": ["In", "addition,", "our", "effective", "tax", "rate", "for", "future", "periods", "could", "be", "negatively", "impacted", "by", "the", "EGEN", "acquisition", "or", "potential", "future", "transactions."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_15_item1a_p76_s2", "idA": "749647_14_item1a_p9_s3", "sentA": "Even if we receive regulatory approval of a product, the approval may limit the indicated uses for which the drug may be marketed.", "sentB": "Key employees may depart if we fail to successfully manage this additional business location or in relation to any uncertainties or difficulties of integration with Celsion.", "type": 1, "words": ["<tag1>", "Even", "if", "we", "receive", "regulatory", "approval", "of", "a", "product,", "the", "approval", "may", "limit", "the", "indicated", "uses", "for", "which", "the", "drug", "may", "be", "marketed.", "<tag2>", "Key", "employees", "may", "depart", "if", "we", "fail", "to", "successfully", "manage", "this", "additional", "business", "location", "or", "in", "relation", "to", "any", "uncertainties", "or", "difficulties", "of", "integration", "with", "Celsion.", "<tag3>"], "wordsA": ["Even", "if", "we", "receive", "regulatory", "approval", "of", "a", "product,", "the", "approval", "may", "limit", "the", "indicated", "uses", "for", "which", "the", "drug", "may", "be", "marketed."], "wordsB": ["Key", "employees", "may", "depart", "if", "we", "fail", "to", "successfully", "manage", "this", "additional", "business", "location", "or", "in", "relation", "to", "any", "uncertainties", "or", "difficulties", "of", "integration", "with", "Celsion."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_16_item1a_p61_s1", "idA": "749647_15_item1a_p20_s4", "sentA": "In addition, we cannot be certain that the product candidates we acquired will be approved for marketing and commercialization, become profitable or remain so or that we will realize operational cost savings or other expected synergies of the acquisition.", "sentB": "In addition, exclusive marketing rights in the United States may be limited if we seek approval for an indication broader than the orphan-designated indication or may be lost if the FDA later determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition.", "type": 1, "words": ["<tag1>", "In", "addition,", "we", "cannot", "be", "certain", "that", "the", "product", "candidates", "we", "acquired", "will", "be", "approved", "for", "marketing", "and", "commercialization,", "become", "profitable", "or", "remain", "so", "or", "that", "we", "will", "realize", "operational", "cost", "savings", "or", "other", "expected", "synergies", "of", "the", "acquisition.", "<tag2>", "In", "addition,", "exclusive", "marketing", "rights", "in", "the", "United", "States", "may", "be", "limited", "if", "we", "seek", "approval", "for", "an", "indication", "broader", "than", "the", "orphan-designated", "indication", "or", "may", "be", "lost", "if", "the", "FDA", "later", "determines", "that", "the", "request", "for", "designation", "was", "materially", "defective", "or", "if", "the", "manufacturer", "is", "unable", "to", "assure", "sufficient", "quantities", "of", "the", "product", "to", "meet", "the", "needs", "of", "patients", "with", "the", "rare", "disease", "or", "condition.", "<tag3>"], "wordsA": ["In", "addition,", "we", "cannot", "be", "certain", "that", "the", "product", "candidates", "we", "acquired", "will", "be", "approved", "for", "marketing", "and", "commercialization,", "become", "profitable", "or", "remain", "so", "or", "that", "we", "will", "realize", "operational", "cost", "savings", "or", "other", "expected", "synergies", "of", "the", "acquisition."], "wordsB": ["In", "addition,", "exclusive", "marketing", "rights", "in", "the", "United", "States", "may", "be", "limited", "if", "we", "seek", "approval", "for", "an", "indication", "broader", "than", "the", "orphan-designated", "indication", "or", "may", "be", "lost", "if", "the", "FDA", "later", "determines", "that", "the", "request", "for", "designation", "was", "materially", "defective", "or", "if", "the", "manufacturer", "is", "unable", "to", "assure", "sufficient", "quantities", "of", "the", "product", "to", "meet", "the", "needs", "of", "patients", "with", "the", "rare", "disease", "or", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_16_item1a_p61_s2", "idA": "749647_15_item1a_p20_s4", "sentA": "In addition, we cannot be certain that the product candidates we acquired will be approved for marketing and commercialization, become profitable or remain so or that we will realize operational cost savings or other expected synergies of the acquisition.", "sentB": "Further, even if we obtain orphan drug exclusivity for a product, that exclusivity may not effectively protect the product from competition because different drugs with different active moieties can be approved for the same condition.", "type": 1, "words": ["<tag1>", "In", "addition,", "we", "cannot", "be", "certain", "that", "the", "product", "candidates", "we", "acquired", "will", "be", "approved", "for", "marketing", "and", "commercialization,", "become", "profitable", "or", "remain", "so", "or", "that", "we", "will", "realize", "operational", "cost", "savings", "or", "other", "expected", "synergies", "of", "the", "acquisition.", "<tag2>", "Further,", "even", "if", "we", "obtain", "orphan", "drug", "exclusivity", "for", "a", "product,", "that", "exclusivity", "may", "not", "effectively", "protect", "the", "product", "from", "competition", "because", "different", "drugs", "with", "different", "active", "moieties", "can", "be", "approved", "for", "the", "same", "condition.", "<tag3>"], "wordsA": ["In", "addition,", "we", "cannot", "be", "certain", "that", "the", "product", "candidates", "we", "acquired", "will", "be", "approved", "for", "marketing", "and", "commercialization,", "become", "profitable", "or", "remain", "so", "or", "that", "we", "will", "realize", "operational", "cost", "savings", "or", "other", "expected", "synergies", "of", "the", "acquisition."], "wordsB": ["Further,", "even", "if", "we", "obtain", "orphan", "drug", "exclusivity", "for", "a", "product,", "that", "exclusivity", "may", "not", "effectively", "protect", "the", "product", "from", "competition", "because", "different", "drugs", "with", "different", "active", "moieties", "can", "be", "approved", "for", "the", "same", "condition."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_16_item1a_p60_s1", "idA": "749647_15_item1a_p37_s1", "sentA": "In addition, there is no guarantee that we will be the first to file a patent application directed to an invention.", "sentB": "Under the Orphan Drug Act, the FDA may designate a drug as an orphan drug if it is a drug intended to treat a rare disease or condition, which is generally defined as a patient population of fewer than 200,000 individuals annually in the United States, or a patient population greater than 200,000 in the United States where there is no reasonable expectation that the cost of developing the drug will be recovered from sales in the United States.", "type": 1, "words": ["<tag1>", "In", "addition,", "there", "is", "no", "guarantee", "that", "we", "will", "be", "the", "first", "to", "file", "a", "patent", "application", "directed", "to", "an", "invention.", "<tag2>", "Under", "the", "Orphan", "Drug", "Act,", "the", "FDA", "may", "designate", "a", "drug", "as", "an", "orphan", "drug", "if", "it", "is", "a", "drug", "intended", "to", "treat", "a", "rare", "disease", "or", "condition,", "which", "is", "generally", "defined", "as", "a", "patient", "population", "of", "fewer", "than", "200,000", "individuals", "annually", "in", "the", "United", "States,", "or", "a", "patient", "population", "greater", "than", "200,000", "in", "the", "United", "States", "where", "there", "is", "no", "reasonable", "expectation", "that", "the", "cost", "of", "developing", "the", "drug", "will", "be", "recovered", "from", "sales", "in", "the", "United", "States.", "<tag3>"], "wordsA": ["In", "addition,", "there", "is", "no", "guarantee", "that", "we", "will", "be", "the", "first", "to", "file", "a", "patent", "application", "directed", "to", "an", "invention."], "wordsB": ["Under", "the", "Orphan", "Drug", "Act,", "the", "FDA", "may", "designate", "a", "drug", "as", "an", "orphan", "drug", "if", "it", "is", "a", "drug", "intended", "to", "treat", "a", "rare", "disease", "or", "condition,", "which", "is", "generally", "defined", "as", "a", "patient", "population", "of", "fewer", "than", "200,000", "individuals", "annually", "in", "the", "United", "States,", "or", "a", "patient", "population", "greater", "than", "200,000", "in", "the", "United", "States", "where", "there", "is", "no", "reasonable", "expectation", "that", "the", "cost", "of", "developing", "the", "drug", "will", "be", "recovered", "from", "sales", "in", "the", "United", "States."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_16_item1a_p61_s3", "idA": "749647_15_item1a_p73_s0", "sentA": "Technologies for the treatment of cancer are subject to rapid change, and the development of treatment strategies that are more effective than our technologies could render our technologies obsolete.", "sentB": "Even after an orphan product is approved, the FDA can subsequently approve the same drug with the same active moiety for the same condition if the FDA concludes that the later drug is safer, more effective or makes a major contribution to patient care.", "type": 1, "words": ["<tag1>", "Technologies", "for", "the", "treatment", "of", "cancer", "are", "subject", "to", "rapid", "change,", "and", "the", "development", "of", "treatment", "strategies", "that", "are", "more", "effective", "than", "our", "technologies", "could", "render", "our", "technologies", "obsolete.", "<tag2>", "Even", "after", "an", "orphan", "product", "is", "approved,", "the", "FDA", "can", "subsequently", "approve", "the", "same", "drug", "with", "the", "same", "active", "moiety", "for", "the", "same", "condition", "if", "the", "FDA", "concludes", "that", "the", "later", "drug", "is", "safer,", "more", "effective", "or", "makes", "a", "major", "contribution", "to", "patient", "care.", "<tag3>"], "wordsA": ["Technologies", "for", "the", "treatment", "of", "cancer", "are", "subject", "to", "rapid", "change,", "and", "the", "development", "of", "treatment", "strategies", "that", "are", "more", "effective", "than", "our", "technologies", "could", "render", "our", "technologies", "obsolete."], "wordsB": ["Even", "after", "an", "orphan", "product", "is", "approved,", "the", "FDA", "can", "subsequently", "approve", "the", "same", "drug", "with", "the", "same", "active", "moiety", "for", "the", "same", "condition", "if", "the", "FDA", "concludes", "that", "the", "later", "drug", "is", "safer,", "more", "effective", "or", "makes", "a", "major", "contribution", "to", "patient", "care."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
{"idB": "749647_17_item1a_p9_s0", "idA": "749647_16_item1a_p72_s0", "sentA": "We have no internal sales or marketing capability.", "sentB": "We have not generated significant revenue and have incurred significant net losses in each year since our inception.", "type": 1, "words": ["<tag1>", "We", "have", "no", "internal", "sales", "or", "marketing", "capability.", "<tag2>", "We", "have", "not", "generated", "significant", "revenue", "and", "have", "incurred", "significant", "net", "losses", "in", "each", "year", "since", "our", "inception.", "<tag3>"], "wordsA": ["We", "have", "no", "internal", "sales", "or", "marketing", "capability."], "wordsB": ["We", "have", "not", "generated", "significant", "revenue", "and", "have", "incurred", "significant", "net", "losses", "in", "each", "year", "since", "our", "inception."], "keywordsA": [], "keywordsB": [], "labels": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1], "probs": [-1, 0, 0, 0, 0, 0, 0, 0, 0, -1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, 1, -1]}
